CEI Podcast for May 31, 2011: FDA Rescinds Approval of Breast Cancer Drug

by Ryan Young on May 31, 2011

in Health and Illness, Healthcare, Personal Liberty, Podcast, Precaution & Risk, Regulation

Have a listen here.

Senior Fellow Greg Conko breaks down the fight over Avastin, a drug used to treat several types of cancer. The FDA is poised to rescind Avastin’s approval for treating breast cancer. It will retain its approval for other cancers. This will make life difficult, and possibly shorter, for some breast cancer patients. Conko believes this battle boils down to one question: who decides which treatments patients can use? Will it be the FDA, or doctors and patients?

Comments on this entry are closed.

Previous post:

Next post: